1. Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy. Issue 8 (10th May 2019) Authors: Lakkis, Z.; Vernerey, D.; Mege, D.; Faucheron, J.‐L.; Panis, Y.; Tuech, J.‐J.; Lefevre, J. H.; Brouquet, A.; Dumont, F.; Borg, C.; Woronoff, A.‐S.; Meurisse, A.; Heyd, B.; Rullier, E. Journal: British journal of surgery Issue: Volume 106:Issue 8(2019) Page Start: 1087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SUN-PO106: Preoperative Sarcopenia and Lymphopenia have an Additive Value for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma. (September 2019) Authors: Grillot, J.; Raillat, J.; Vienot, A.; Vuitton, L.; Koch, S.; Algros, M.P.; Turco, C.; Chanut, L.; Prothe, C.; Borg, C.; D'engremont, C. Journal: Clinical nutrition Issue: Volume 38(2019)Supplement 1 Page Start: S98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. (4th May 2018) Authors: Asgarova, A.; Asgarov, K.; Godet, Y.; Peixoto, P.; Nadaradjane, A.; Boyer-Guittaut, M.; Galaine, J.; Guenat, D.; Mougey, V.; Perrard, J.; Pallandre, J. R.; Bouard, A.; Balland, J.; Tirole, C.; Adotevi, O.; Hendrick, E.; Herfs, M.; Cartron, P. F.; Borg, C.; Hervouet, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. (4th May 2018) Authors: Adotevi, O.; Godet, Y.; Galaine, J.; Lakkis, Z.; Idirene, I.; Certoux, J. M.; Jary, M.; Loyon, R.; Laheurte, C.; Kim, S.; Dormoy, A.; Pouthier, F.; Barisien, C.; Fein, F.; Tiberghien, P.; Pivot, X.; Valmary-Degano, S.; Ferrand, C.; Morel, P.; Delabrousse, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2345 Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (dcf) compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. (September 2015) Authors: Kim, S.; Paget-Bailly, S.; Fiteni, F.; Messager, M.; Nguyen, T.; Mathieu, P.; Lamfichekh, N.; Fein, F.; Fratte, S.; Cleau, D.; Calcagno, F.; Lakkis, Z.; Jary, M.; Sakek, N.; Jacquin, M.; Foubert, A.; Bonnetain, F.; Mariette, C.; Borg, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2145 Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase open label trial. (September 2015) Authors: Taieb, J.; Borg, C.; Lecomte, T.; Lepere, C.; Chatellier, T.; Smith, D.; Dubreuil, P; Mansfield, C.; Moussy, A.; Hermine, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1320 Pelvic chemoradiation after chemotherapy in patients with advanced anal squamous cell carcinoma. (May 2022) Authors: Boustani, J.; Grave, A.; De Bari, B.; Mandy, P.; Boulbair, F.; Benhmida, S.; Noirclerc, M.; Monasterolo, P.; Kim, S.; Borg, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LBA6 UCPVax therapeutic vaccination promotes cytotoxic and Th1 polarized antitumor CD4 T cells and epitope spreading in patients with advanced non-small cell lung cancer. (December 2022) Authors: Adotevi, O.; Laheurte, C.; Boullerot, L.; Malfroy, M.; Richard, T.; Cuche, L.; Seffar, E.; Kaulek, V.; Jacquin, M.; Orillard, E.; Eberst, G.; Jandus, C.; Westeel, V.; Borg, C.; Godet, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays. (June 2018) Authors: Guidicelli, G.; Visentin, J.; Franchini, N.; Borg, C.; Merville, P.; Couzi, L.; Taupin, J.‐L. Journal: HLA Issue: Volume 91:Number 6(2018) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. Issue 1 (January 2017) Authors: Kim, S.; Paget-Bailly, S.; Messager, M.; Nguyen, T.; Mathieu, P.; Lamfichekh, N.; Fein, F.; Fratté, S.; Cléau, D.; Lakkis, Z.; Jary, M.; Sakek, N.; Jacquin, M.; Foubert, A.; Bonnetain, F.; Mariette, C.; Fiteni, F.; Borg, C. Journal: European journal of surgical oncology Issue: Volume 43:Issue 1(2017:Jan.) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗